Edwards Lifesciences Profit Margin 2010-2024 | EW

Current and historical gross margin, operating margin and net profit margin for Edwards Lifesciences (EW) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Edwards Lifesciences net profit margin as of December 31, 2024 is 72.93%.
Edwards Lifesciences Annual Profit Margins
Edwards Lifesciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.608B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $187.725B 22.76
Intuitive Surgical (ISRG) United States $176.405B 80.93
Alcon (ALC) Switzerland $46.824B 31.12
IDEXX Laboratories (IDXX) United States $34.032B 39.36
IQVIA Holdings (IQV) United States $31.084B 17.20
DexCom (DXCM) United States $26.777B 41.39
Mettler-Toledo (MTD) United States $24.611B 28.69
STERIS (STE) Ireland $22.269B 25.47
Waters (WAT) United States $21.897B 31.05
SONOVA HOLDING (SONVY) Switzerland $17.380B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.612B 14.91
Hologic (HOLX) United States $13.861B 14.96
Sysmex ADR (SSMXY) Japan $11.941B 37.44
Penumbra (PEN) United States $10.300B 93.17
Globus Medical (GMED) United States $10.068B 23.31
Masimo (MASI) United States $9.002B 37.78
Teleflex (TFX) United States $6.407B 9.86
Glaukos (GKOS) United States $5.567B 0.00
Integer Holdings (ITGR) United States $3.967B 22.27
PROCEPT BioRobotics (PRCT) United States $3.194B 0.00
Veracyte (VCYT) United States $2.311B 41.76
TransMedics (TMDX) United States $2.265B 66.61
Nihon Kohden (NHNKY) Japan $2.205B 12.06
LivaNova (LIVN) United Kingdom $2.135B 12.96
Elekta AB (EKTAY) Sweden $1.995B 17.93
Integra LifeSciences Holdings (IART) United States $1.698B 8.59
Alphatec Holdings (ATEC) United States $1.462B 0.00
Tandem Diabetes Care (TNDM) United States $1.274B 0.00
OPKO Health (OPK) United States $1.115B 0.00
Paragon 28 (FNA) United States $1.096B 0.00
Artivion (AORT) United States $1.034B 98.32
RxSight (RXST) United States $1.022B 0.00
Pulse Biosciences (PLSE) United States $0.990B 0.00
AxoGen (AXGN) United States $0.820B 0.00
IRadimed (IRMD) United States $0.667B 34.99
AVANOS MEDICAL, INC (AVNS) United States $0.659B 10.61
Mesa Laboratories (MLAB) United States $0.645B 14.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.636B 0.00
OrthoPediatrics (KIDS) United States $0.598B 0.00
SiBone (SIBN) United States $0.596B 0.00
Beta Bionics (BBNX) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.525B 0.00
Delcath Systems (DCTH) United States $0.425B 0.00
NeuroPace (NPCE) United States $0.400B 0.00
AngioDynamics (ANGO) United States $0.380B 0.00
Pacific Biosciences Of California (PACB) United States $0.351B 0.00
Semler Scientific (SMLR) United States $0.347B 7.37
ClearPoint Neuro (CLPT) United States $0.329B 0.00
CVRx (CVRX) United States $0.318B 0.00
Tactile Systems Technology (TCMD) United States $0.313B 16.73
Nevro (NVRO) United States $0.224B 0.00
Inogen (INGN) United States $0.192B 0.00
Accuray (ARAY) United States $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.177B 0.00
LENSAR (LNSR) United States $0.166B 0.00
908 Devices (MASS) United States $0.158B 0.00
Spectral Diagnostics (EDTXF) Canada $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Sight Sciences (SGHT) United States $0.123B 0.00
KORU Medical Systems (KRMD) United States $0.117B 0.00
Rapid Micro Biosystems (RPID) United States $0.114B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Atossa Genetics (ATOS) United States $0.087B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
Sensus Healthcare (SRTS) United States $0.078B 11.82
EDAP TMS S.A (EDAP) France $0.073B 0.00
Zomedica (ZOMDF) United States $0.057B 0.00
Hyperfine (HYPR) United States $0.056B 0.00
Microbot Medical (MBOT) United States $0.052B 0.00
EnVVeno Medical (NVNO) United States $0.046B 0.00
Vicarious Surgical (RBOT) United States $0.039B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.027B 0.00
Envoy Medical (COCH) United States $0.026B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
NexGel (NXGL) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Aspira Women's Health (AWH) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00